Published in J Neurol Neurosurg Psychiatry on August 01, 1997
Conceptualizing lennox-gastaut syndrome as a secondary network epilepsy. Front Neurol (2014) 0.93
18 F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma. EJNMMI Res (2014) 0.75
Positron emission tomography and the central nervous system. Arch Dis Child (1999) 0.75
Positron emission tomography study of human brain functional development. Ann Neurol (1987) 4.89
Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr (1979) 3.18
Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol (1990) 2.12
Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr (1984) 1.75
Focal abnormalities detected by 18FDG PET in epileptic encephalopathies. Arch Dis Child (1996) 1.48
Determination of object contour from projections for attenuation correction in cranial positron emission tomography. J Comput Assist Tomogr (1982) 1.26
Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomography. Ann Neurol (1992) 1.05
Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia (1993) 1.04
Tracer-kinetic models for measuring cerebral blood flow using externally detected radiotracers. J Cereb Blood Flow Metab (1987) 1.01
Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cereb Blood Flow Metab (1990) 0.99
Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography. Eur J Nucl Med (1987) 0.98
Evolutional changes of cortical hypometabolism in West's syndrome. Lancet (1994) 0.97
The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography. Ann Neurol (1987) 0.97
Barbiturates reduce human cerebral glucose metabolism. Neurology (1986) 0.96
The influence of biological and technical factors on the variability of global and regional brain metabolism of 2-[18F]fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab (1992) 0.95
The age-dependent epileptic encephalopathies. J Child Neurol (1992) 0.90
Cerebral glucose metabolism in the Lennox-Gastaut syndrome. Ann Neurol (1987) 0.89
Effect of valproate on human cerebral glucose metabolism. Epilepsia (1991) 0.89
Infantile spasms: III. Prognostic implications of bitemporal hypometabolism on positron emission tomography. Ann Neurol (1996) 0.88
Positron emission tomography in two cases of childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Neurology (1982) 0.87
Positron emission tomography in three cases of Lennox-Gastaut syndrome. Jpn J Psychiatry Neurol (1988) 0.86
Epileptic encephalopathies of early childhood. Curr Opin Neurol Neurosurg (1992) 0.85
Cerebral glucose metabolic rates after 30 and 45 minute acquisitions: a comparative study. J Nucl Med (1992) 0.84
The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography. J Cereb Blood Flow Metab (1987) 0.84
Complex partial seizures: cerebellar metabolism. Epilepsia (1987) 0.84
Morphological and biochemical analysis of a brain biopsy in a case of idiopathic Lennox-Gastaut syndrome. Epilepsia (1988) 0.83
Influence of size of regions of interest on PET evaluation of caudate glucose consumption. J Comput Assist Tomogr (1992) 0.81
Quantitative comparison of cerebral glucose metabolic rates from two positron emission tomographs. J Nucl Med (1989) 0.79
PET studies of patients with partial epilepsy: visual interpretation vs. semi-quantification/quantification. Acta Neurol Scand Suppl (1994) 0.79
Human cerebral glucose metabolism determined by positron emission tomography: a revisit. J Cereb Blood Flow Metab (1987) 0.78
Absolute quantitation in neurological PET: do we need it? J Cereb Blood Flow Metab (1991) 0.78
On the influence of spatial resolution and of the size and form of regions of interest on the measurement of regional cerebral metabolic rates by positron emission tomography. J Neural Transm Suppl (1992) 0.77
Reflex absence epilepsy. Epilepsia (1988) 0.76
Vagal nerve stimulation in epileptic encephalopathies. Pediatrics (1999) 5.32
Interaction of lamotrigine with sodium valproate. Lancet (1993) 2.19
Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med (1996) 1.99
Simultaneous PET and MR imaging. Phys Med Biol (1997) 1.95
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol (1998) 1.94
Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections. J Neurol Neurosurg Psychiatry (2005) 1.82
Influence of anatomic correction for transposition of the great arteries on myocardial perfusion: radionuclide imaging with technetium-99m 2-methoxy isobutyl isonitrile. J Am Coll Cardiol (1994) 1.68
A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med (1999) 1.67
Cold pressor test in detection of coronary heart-disease and cardiomyopathy using technetium-99m gated blood-pool imaging. Lancet (1979) 1.65
Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying. Gastroenterology (1984) 1.61
Diagnosis and management of benign intracranial hypertension. Arch Dis Child (1998) 1.52
Effect of lamotrigine on cognition in children with epilepsy. Neurology (2006) 1.48
Focal abnormalities detected by 18FDG PET in epileptic encephalopathies. Arch Dis Child (1996) 1.48
Plasma catecholamines in foetal and adult sheep. J Physiol (1975) 1.43
Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. Eur J Cancer (2012) 1.41
Psychotic and severe behavioural reactions with vigabatrin: a review. Acta Neurol Scand (1996) 1.39
Clinical events relating to intraventricular haemorrhage in the newborn. Arch Dis Child (1979) 1.37
Effect of thyroid failure on the pituitary-adrenal axis. Lancet (1969) 1.35
Being equipped for clinical PET. Lancet (2000) 1.35
18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT. Leuk Lymphoma (2000) 1.34
Quantitative lacrimal scintillography. I. Method and physiological application. Br J Ophthalmol (1975) 1.31
FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer (2002) 1.29
Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med (1999) 1.24
An improved analytical detector response function model for multilayer small-diameter PET scanners. Phys Med Biol (2003) 1.24
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg (1999) 1.24
Timing of intraventricular haemorrhage. Arch Dis Child (1977) 1.22
The role of long acting thyroid stimulator in neonatal thyrotoxicosis. Clin Endocrinol (Oxf) (1972) 1.17
Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia (2005) 1.17
Functional significance of coronary collateral circulation during dynamic exercise evaluated by thallium-201 myocardial scintigraphy. Br Heart J (1980) 1.16
Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med (1996) 1.14
99Tcm-DTPA for the measurement of glomerular filtration rate. Br J Radiol (1976) 1.14
Fluorine-18-FDG PET in Paget's disease of bone. J Nucl Med (1997) 1.10
Quantitative lacrimal scintillography. Arch Ophthalmol (1978) 1.10
Optimization of noise-equivalent count rates in 3D PET. Phys Med Biol (1996) 1.09
Thoracic respiratory motion estimation from MRI using a statistical model and a 2-D image navigator. Med Image Anal (2011) 1.09
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma. Ann Oncol (2010) 1.08
Inappropriate use of carbamazepine and vigabatrin in typical absence seizures. Dev Med Child Neurol (1998) 1.08
Letter to the editor re: positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study. Mol Imaging Biol (2013) 1.07
Magnetic resonance imaging of coarctation of the aorta in infants: use of a high field strength. Br Heart J (1989) 1.04
A study of artefacts in simultaneous PET and MR imaging using a prototype MR compatible PET scanner. Phys Med Biol (1999) 1.04
Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions. Eur J Nucl Med (1999) 1.04
Changes in regional brain (18)F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes (2001) 1.03
Sequential bone scans and chest radiographs in the postoperative management of early breast cancer. Br J Surg (1983) 1.03
Measuring glomerular filtration-rate. Lancet (1969) 1.02
Mycoplasma pneumoniae infection and neurological disease. Arch Dis Child (1993) 1.00
Addison's disease: a clinical study. Guys Hosp Rep (1969) 1.00
Serial quantitative imaging with 99Tcm-DTPA in pediatric renal transplantation. Clin Nephrol (1979) 1.00
Randoms variance reduction in 3D PET. Phys Med Biol (1999) 1.00
An improved method for sacro-iliac joint imaging: a study of normal subjects, patients with sacro-iliitis and patients with low back pain. Clin Radiol (1981) 0.99
Quantitative lacrimal scintillography. II. Lacrimal pathology. Br J Ophthalmol (1975) 0.99
The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging (2004) 0.99
Analysis and comparison of two methods for motion correction in PET imaging. Med Phys (2012) 0.98
A study of the effects of sumatriptan on myocardial perfusion in healthy female migraineurs using 13NH3 positron emission tomography. Neurology (1997) 0.98
PET and NMR dual acquisition (PANDA): applications to isolated, perfused rat hearts. NMR Biomed (1997) 0.98
Speech-related visualization of laryngeal muscles with fluorine-18-FDG. J Nucl Med (1996) 0.97
Quantification of skeletal kinetic indices in Paget's disease using dynamic 18F-fluoride positron emission tomography. J Bone Miner Res (2002) 0.97
Early-onset benign occipital seizure susceptibility syndrome. Epilepsia (1997) 0.97
Standard dose 131I therapy for hyperthyroidism caused by autonomously functioning thyroid nodules. Clin Endocrinol (Oxf) (1979) 0.97
Serum thyroglobulin in thyroid cancer. Lancet (1981) 0.95
The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid. Br J Radiol (1987) 0.95
Radionuclide measurement of left ventricular ejection fraction in tricuspid atresia. Br Heart J (1984) 0.94
Infantile Parkinsonism-dystonia and elevated dopamine metabolites in CSF. Neurology (2004) 0.94
Positron emission tomography for urological tumours. BJU Int (2003) 0.93
Evaluation of Technetium-labeled red cells for determination of red cell volume in man. J Nucl Med (1972) 0.93
A major role for viruses in acute childhood encephalopathy. Lancet (1986) 0.93
Gliomatosis cerebri: disconnection of the cortical grey matter, demonstrated on PET scan. Br J Neurosurg (1998) 0.93
FDG-PET screening for cerebral metastases in patients with suspected malignancy. Nucl Med Commun (1996) 0.92
Validation of a rapid computerized method of measuring 99mTc pertechnetate uptake for routine assessment of thyroid structure and function. J Clin Endocrinol Metab (1973) 0.91
Polyuria after cardiac surgery. Br Med J (1970) 0.91
Dynamic renal transplant imaging with Tc-99m DTPA (Sn) supplemented by a transplant perfusion index in the management of renal transplants. J Nucl Med (1978) 0.91
Effects of histamine on lung permeability in normal and asthmatic subjects. Thorax (1985) 0.91
Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancer. Eur J Nucl Med (2001) 0.90
A browser based image bank, useful tool or expensive toy? Med Inform (Lond) (1998) 0.90
Superiority of radionuclide over oximetric measurement of left to right shunts. Br Heart J (1985) 0.90
Interindividual differences in the pituitary-thyroid axis influence the interpretation of thyroid function tests. Clin Endocrinol (Oxf) (1993) 0.90
Mucopolysaccharidoses: ultrastructure of leukocyte inclusions. Ann Neurol (1980) 0.89
Benign hereditary chorea--response to steroids. Dev Med Child Neurol (1985) 0.89
Registration and display of the combined bone scan and radiograph in the diagnosis and management of wrist injuries. Eur J Nucl Med (1991) 0.89
Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand (1995) 0.89
Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy. Neurology (2000) 0.89
Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J Nucl Med (1988) 0.89
Nuclear medicine in clinical cardiology. Br Med Bull (1980) 0.89
Lower limb extensor moments in children with spastic diplegic cerebral palsy. Gait Posture (2004) 0.88
FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy. Eur J Nucl Med (2001) 0.88
Differences in regional bone metabolism at the spine and hip: a quantitative study using (18)F-fluoride positron emission tomography. Osteoporos Int (2012) 0.88
Measurement of radiation dose to the thyroid using positron emission tomography. Br J Radiol (1987) 0.88
Fast generation of 4D PET-MR data from real dynamic MR acquisitions. Phys Med Biol (2011) 0.88
Methods of investigation in the diagnosis and management of thyroid carcinoma. World J Surg (1981) 0.88
Prevalence of inappropriate drug treatment in patients with hyperthyroidism. Br Med J (Clin Res Ed) (1985) 0.88
Tetraethyl lead poisoning from gasoline sniffing. JAMA (1978) 0.88
Non-invasive method for measuring intracranial pressure in normal newborn infants. Dev Med Child Neurol (1977) 0.88
Use of radionuclide labelled microspheres to show the distribution of the pulmonary perfusion with multifocal pulmonary blood supply. Br Heart J (1984) 0.88
Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography. Br J Surg (1999) 0.87
The evaluation of radioiodine therapy for thyroid patients using a fixed-dose regime. Br J Radiol (1986) 0.87
Positron emission tomography in imaging spinal cord tumors. J Child Neurol (2000) 0.87
Algorithms for calculating detector efficiency normalization coefficients for true coincidences in 3D PET. Phys Med Biol (1998) 0.86
Radionuclide measurement of right ventricular function in atrial septal defect, ventricular septal defect and complete transposition of the great arteries. Am J Cardiol (1986) 0.86
Magnetic resonance imaging at a high field strength of ventricular septal defects in infants. Br Heart J (1989) 0.86